Management of ureteral and renal pelvic recurrence after cystectomy.
Relatively few data are available on UT TCC following cystectomy. In most circumstances nephroureterectomy is the treatment of choice. The risk of bilateral disease is small (2% to 4%); however, in patients with bilateral UT TCC, a solitary kidney, or poor renal function and low-stage, low-grade TCC, renal preservation by local resection and/or topical therapy may be effective. In high-grade or high-stage disease, whenever feasible nephroureterectomy should be performed.
Braslis
K G
KG
Department of Urology, University of Miami School of Medicine, Florida.
Soloway
M S
MS
D002295:Carcinoma, Transitional Cell / Q000556:secondary* / Q000628:therapy; D015653:Cystectomy; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000556:secondary* / Q000628:therapy; D007682:Kidney Pelvis; D008297:Male; D014516:Ureteral Neoplasms / Q000556:secondary* / Q000628:therapy; D001749:Urinary Bladder Neoplasms / Q000473:pathology* / Q000601:surgery